Cows may offer clues to improving fertility in women
With funding from the National Institutes of Health and United States Department of Agriculture, MSU researchers will look to bring a better understanding about fertility treatments in women by studying the effect of hormones on ovulation and reproduction in cows. James Ireland, professor in reproductive biology, will lead the five-year study with Keith Latham, co-director of the Reproductive and Developmental Sciences Program at MSU. Richard Leach, chair of MSU’s Department of Obstetrics, Gynecology and Reproductive Biology, will also contribute to the project.
The way breast cancer genes act could predict your treatment
A Michigan State University breast cancer researcher has shown that effective treatment options can be predicted based on the way certain breast cancer genes act or express themselves. The research, published in the journal Oncogene, offers up proof that gene expression patterns can help direct the type of therapy a patient might receive, paving the way for more targeted and personalized approaches to care.
MSU Gran Fondo ranks among top Gran Fondos in the US
The Michigan State University College of Human Medicine Gran Fondo was recently named one of the top U.S. Gran Fondos of 2017 by Gran Fondo Guide. The June 24 event is ranked fourth among 15 mass-participation cycling events.
Ronald Chandler, PhD, receives early career award for ovarian cancer research
Ronald Chandler, assistant professor in the College of Human Medicine’s Department of Obstetrics, Gynecology and Reproductive Biology, has received a 2017 Liz Tilberis Early Career Award from the Ovarian Cancer Research Fund Alliance. The Liz Tilberis Early Career Award recognizes junior faculty who are committed to an investigative career in the field of ovarian cancer research. The intent of these awards is to support a substantial time commitment to research and academic endeavors in ovarian cancer.
College of Human Medicine students perform better in new medical curriculum
After just 12 weeks of introducing a new medical curriculum to its incoming College of Human Medicine students, Michigan State University is finding that these future physicians are already ahead of the game in their academic and clinical skills.
“Students even at seven weeks were already clinically performing essentially at the level of students who were at the end of their first year in the previous curriculum,” said Aron Sousa, senior associate dean for academic affairs for the medical college. “It’s the experiential learning aspect of the program that’s making this happen.”
College of Human Medicine reinvents curriculum
Striving to remain at the forefront of medical innovation, the Michigan State University College of Human Medicine implemented a new curriculum, which turns the previous format on its head.
MDHHS awards $500,000 planning grant to MSU College of Human Medicine for Flint registry planning
The Michigan Department of Health and Human Services (MDHHS) today announced a one-year grant of $500,000 for the Michigan State University College of Human Medicine for the planning of a registry for Flint residents.
One of the Flint Water Advisory Task Force recommendations included the creation of Registry for the long-term tracking of residents exposed to Flint water from April 2014 to present. Through this planning grant, MSU College of Human Medicine and the MSU-Hurley Children’s Hospital Pediatric Public Health Initiative, led by Dr. Mona Hanna-Attisha, will continue working with many community partners including the Greater Flint Health Coalition to build upon approximately one year of registry planning, building, convening and advocacy in order to develop the foundation for the registry. The intent of the registry will be to that identify, track and support Flint Water Crisis victims.
MSU doctor bravely champions the children of Flint
Big Ten Network's LiveBIG features Mona Hanna-Attisha, MD, MPH, FAAP, director, pediatric residency at Hurley Children’s Hospital and assistant professor of pediatrics at Michigan State University College of Human Medicine.
Promising new drug stops spread of melanoma by 90 percent
Michigan State University researchers have discovered that a chemical compound, and potential new drug, reduces the spread of melanoma cells by up to 90 percent. The man-made, small-molecule drug compound goes after a gene’s ability to produce RNA molecules and certain proteins in melanoma tumors. “It’s been a challenge developing small-molecule drugs that can block this gene activity that works as a signaling mechanism known to be important in melanoma progression,” said Richard Neubig, a pharmacology professor and co-author of the study. “Our chemical compound is actually the same one that we’ve been working on to potentially treat the disease scleroderma, which now we’ve found works effectively on this type of cancer.”